Otolaryngeal Cancer

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Otolaryngeal Cancer trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

TerminatedPhase 4

NCT03040024

Delirium Prevention With Ketamine in Ear, Nose, and Throat (ENT) Patients

The goal of this prospective randomized double blinded placebo controlled study is to investigate if a single dose of ketamine in addition to standard anesthesi…

United States71 participantsStarted 2017-03-17

Treatment: Ketamine, Placebo